Physician Assistant · Wilson, NC
NPI
1205262029
Since 2013
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
303 Green St E
Wilson, NC, 27893
Phone (252) 243-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,334
188 services
Medicare patients, 2024
82
Average age 71
Drug cost, 2024
$5.1M
8,712 prescriptions
Company payments, 2025
$43K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Surovchak was code 83036 (blood count), 77 times for 37 patients. In total David J Surovchak billed 188 services in 33 codes, and Medicare paid $4,334.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 77 | 37 | $6.86 | $528 |
| 99213 Office E&M - Established | Office | 19 | 19 | $50.35 | $957 |
| 99203 Office E&M - New | Office | 13 | 13 | $65.09 | $846 |
By year: 2022 $6,815 for 276 services; 2023 $3,883 for 187 services; 2024 $4,334 for 188 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 77 | 37 | $6.86 | $528 |
Medicare prescription drug claims, 2024
In 2024, the drug David J Surovchak prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 580 prescriptions and refills. In total David J Surovchak wrote 8,712 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 580 | 580 | 72 | $2.2M |
| Atorvastatin Calcium Generic | 549 | 1,284 | 142 | $3,577 |
| Amlodipine Besylate Generic | 523 | 1,110 | 133 | $2,354 |
| Rosuvastatin Calcium Generic | 352 | 752 | 92 | $2,722 |
| Metoprolol Succinate Generic | 253 | 556 | 64 | $2,156 |
| Losartan Potassium Generic | 230 | 491 | 53 | $1,280 |
| Gabapentin Generic | 197 | 362 | 49 | $2,752 |
| Jardiance Empagliflozin | 181 | 382 | 49 | $219K |
| Furosemide Generic | 148 | 280 | 45 | $642 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 147 | 164 | 45 | $3,864 |
| Omeprazole Generic | 138 | 298 | 33 | $2,052 |
| Carvedilol Generic | 137 | 220 | 26 | $747 |
| Potassium Chloride Generic | 133 | 251 | 36 | $1,926 |
| Dovato Dolutegravir Sodium/Lamivudine | 132 | 132 | 14 | $378K |
| Pantoprazole Sodium Generic | 126 | 235 | 28 | $571 |
Brand drugs: 2,444 claims; generic drugs: 6,213 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Surovchak $43K ($43K in general payments such as food, travel and fees) from 7 companies. The largest payer was Gilead Sciences, Inc. with $27K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.